0001437749-20-011862.txt : 20200527 0001437749-20-011862.hdr.sgml : 20200527 20200527212854 ACCESSION NUMBER: 0001437749-20-011862 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190315 FILED AS OF DATE: 20200527 DATE AS OF CHANGE: 20200527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fraser Craig CENTRAL INDEX KEY: 0001557420 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39290 FILM NUMBER: 20916775 MAIL ADDRESS: STREET 1: AEGERION PHARMACEUTICALS, INC. STREET 2: 101 MAIN STREET, SUITE 1850 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WINDTREE THERAPEUTICS INC /DE/ CENTRAL INDEX KEY: 0000946486 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171943 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 KELLY ROAD STREET 2: SUITE 100 CITY: WARRINGTON STATE: PA ZIP: 18976 BUSINESS PHONE: 2154889300 MAIL ADDRESS: STREET 1: 2600 KELLY ROAD STREET 2: SUITE 100 CITY: WARRINGTON STATE: PA ZIP: 18976 FORMER COMPANY: FORMER CONFORMED NAME: DISCOVERY LABORATORIES INC /DE/ DATE OF NAME CHANGE: 19971201 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 19961121 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN INC DATE OF NAME CHANGE: 19950609 4/A 1 rdgdoc.xml FORM 4/A X0306 4/A 2019-03-15 2019-03-19 0000946486 WINDTREE THERAPEUTICS INC /DE/ WINT 0001557420 Fraser Craig 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 1 1 President and CEO Common Stock 2019-03-15 4 F 0 18023 0 D 63337 D Common Stock 441 I By Trust Holding amount represents issuer's matching stock contribution pursuant to 401(k) plan. This amended Form 4 is being filed solely to report that the number of shares withheld for tax liability upon the vesting of an RSU award represented a disposition of 18,023 shares rather than 20,641 shares as was reported on the Form 4 filed on March 19, 2019. All other information remains the same. The amounts reflected on this Form 4 have not been adjusted for a 1-for-3 reverse stock split effective April 29, 2020. /s/ Craig Fraser 2020-05-27